HERTRAZ 150MG

What is HERTRAZ 150MG?

HERTRAZ 150MG is an anti-cancer medication containing Trastuzumab as its active ingredient. It is a monoclonal antibody that specifically targets the HER2 (human epidermal growth factor receptor 2) protein found in some types of breast and gastric cancers. By blocking HER2 receptors, HERTRAZ 150MG helps stop the growth and spread of cancer cells.

It is available in lyophilized powder form for intravenous infusion, administered under medical supervision.

---

What is the Use of HERTRAZ 150MG?

HERTRAZ 150MG is prescribed for the treatment of:

• HER2-positive breast cancer (early-stage and metastatic)

• HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma

It can be used alone or in combination with chemotherapy depending on the patient’s condition.

---

Benefits of HERTRAZ 150MG

• Targeted therapy: Selectively attacks HER2-positive cancer cells, sparing healthy tissue.

• Improves survival rates: Shown to increase disease-free and overall survival in HER2-positive cancers.

• Prevents recurrence: Reduces the risk of cancer returning after surgery or chemotherapy.

• Enhances effectiveness of chemotherapy when used in combination.

---

How HERTRAZ 150MG Works

HERTRAZ 150MG (Trastuzumab) binds to HER2 receptors on the surface of cancer cells. This action blocks growth signals and activates the immune system to destroy these cells, helping control tumor growth and spread.

---

Side Effects of HERTRAZ 150MG

Common Side Effects:

• Fever and chills

• Fatigue or weakness

• Nausea, vomiting, or diarrhea

• Headache

• Pain at the injection site

Serious Side Effects:

• Heart-related issues (heart failure, irregular heartbeat)

• Severe allergic reactions

• Breathing difficulties

• Lung inflammation (rare)

---

Precautions & Warnings

• Must be administered under medical supervision only.

• Heart function tests should be performed before and during treatment.

• Avoid use during pregnancy and breastfeeding unless approved by a doctor.

• Inform your doctor about any heart disease or previous chemotherapy history.

---

Storage & Administration

• Store at 2°C–8°C (Refrigerated).

• Do not freeze or shake the vial.

• Reconstitute and administer by a qualified healthcare professional only.

---

Product Summary

• Product Name: HERTRAZ 150MG Injection

• Salt Name: Trastuzumab

• Strength: 150 mg

• Manufacturer: Mylan Pharmaceuticals Pvt. Ltd.

• Storage: Store at 2°C–8°C (Refrigerated). Do not freeze.

• Presentation: Lyophilized powder vial for intravenous infusion

15 FAQs – HERTRAZ 150MG

1. What is HERTRAZ 150MG used for?
It treats HER2-positive breast and gastric cancers.

2. What is the active ingredient in HERTRAZ 150MG?
The active ingredient is Trastuzumab.

3. How does HERTRAZ 150MG work?
It targets HER2 receptors on cancer cells and blocks their growth signals.

4. How is HERTRAZ 150MG administered?
By intravenous (IV) infusion under hospital supervision.

5. How often is HERTRAZ 150MG given?
Usually every 1 to 3 weeks, depending on treatment protocol.

6. Can HERTRAZ 150MG be used alone?
Yes, or in combination with chemotherapy medicines like paclitaxel or cisplatin.

7. What are the common side effects?
Fever, chills, nausea, diarrhea, and fatigue.

8. Can HERTRAZ 150MG cause heart problems?
Yes, it may affect heart function; regular cardiac monitoring is required.

9. Is it safe during pregnancy?
No, it should be avoided during pregnancy and breastfeeding.

10. Can I drive after receiving HERTRAZ 150MG?
If you feel dizzy or tired, avoid driving or operating machinery.

11. How long does HERTRAZ 150MG treatment last?
The duration depends on your cancer type and response to therapy.

12. What should I do if I miss a dose?
Contact your doctor immediately to reschedule.

13. Does HERTRAZ 150MG affect immunity?
It targets cancer cells and doesn’t usually suppress normal immune function.

14. How should HERTRAZ 150MG be stored?
Keep refrigerated (2°C–8°C) and protected from light.

15. Who manufactures HERTRAZ 150MG?
Manufactured by Mylan Pharmaceuticals Pvt. Ltd.